Anupam Rasayan India Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ivrortpewdcwc02btuxr8lwa.pdf

Key Takeaways


The Agrochem Reset

Vishal Thakkar: “I appreciate this is a matter of concern for each of us. The only thing that I can say is the reflective will be when I get my sales back -- sales growth back because sales is there, but it's not sufficient enough.”

Order Book & Commercialization Pipeline


Margins: The 31% Print and the 26–28% Guide

Vishal Thakkar: “Both on polymer and pharma, we should have an upward bias on margins. And these are very niche applications, especially in polymer, which will ensure that our ability to ask for and maintain that margin should be there.”

Working Capital: The Overhang

Vishal Thakkar: “I believe that the moment we start achieving the growth and the reduction in the working capital days, there will be a very strong conversion of EBITDA to operating cash flows.”

Capex & Capacity


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth30–35% YoY increase (standalone basis)FY26
Order book commercializationMajority of remaining INR10,700 cr order book (INR3,100 cr already live) to be commercializedFY26
US end-market shareHigh teens percentage of sales12–18 months (by end of next year)
Japan contributionApproximately one-third of sales2–3 years
LOI pipeline peak revenueLarge part of peak revenue from current LOI pipelineBy FY28
New US contractsBoth new US contracts (one signed, one LOI) to be commercialized with significant revenue additionNext year (FY26)
Working capital days180–200 days18–24 months
Green energy share65% of electricity needs met through green energyFuture (no specific date)
Promoter warrant proceedsINR270 cr primarily for debt reductionQ1 FY26
Q4 FY25 revenue~15% growth QoQ to achieve mid-teens full-year declineQ4 FY25

Key Metrics

MetricQ3 FY25
Operating revenue (consolidated)₹390 cr, +32% YoY and +33% QoQ
EBITDA including other income₹121 cr, +48% YoY
EBITDA margin31%, up 389 bps YoY
Profit after tax₹54 cr, +108% YoY
9M FY25 operating revenue₹938 cr, -13% YoY
9M FY25 EBITDA margin28%
9M FY25 PAT₹97 cr, vs ₹127 cr in 9M FY24
FY26 revenue growth target30% to 35% on standalone basis
FY25 full-year revenue growthMid-teens degrowth on standalone basis
Order book₹10,700 cr, spread over 5–6 years; ₹3,100 cr already commercialized
Revenue from LOIs and contracts20% to 25% of FY25 revenue
Agrochem share of revenue50%–55% in 9M FY25
Top 10 customer concentration63% of total revenue
Gross debt₹1,200 cr as of Dec 31, 2024, vs ₹1,270 cr as of Sep 30, 2024
Capex completed (of planned ₹670 cr)₹650 cr as of Dec 31, 2024
Capacity30,000 tons, up from 27,000 tons